Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1377-1381

  Scheja, Agneta ^a   Elborgh, Renate ^a   Wildt, Marie ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Capillaries; Capillary density; Capillary microscopy; Childhood dermatomyositis; Juvenile dermatomyositis; Mixed connective tissue disease

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CAPILLARY DENSITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSCOPY; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; CAPILLARIES; CHILD; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIXED CONNECTIVE TISSUE DISEASE; NAILS; REGIONAL BLOOD FLOW;

EID: 0033042815     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bohan A, Peter J. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
2. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966;45:261-89.
3. Falcini F, Trapani S, Ermini M, Taccetti G, Bartolozzi G. Systemic vasculitis in juvenile dermatomyositis: a fatal case. Clin Exp Rheumatol 1995;13:531-2.
4. Banker BQ. Dermatomyositis of childhood: ultrastructural alterations of muscle and intramuscular blood vessel. J Neuropathol Exp Neurol 1975;34:46-75.
5. Carpenter S, Karpati G, Rothman S, Watters G. The childhood type of dermatomyositis. Neurology 1976;26:952-62.
6. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "Wide-Field" microscopy. Arthritis Rheum 1973;16:619-28.
7. Maricq HR, LeRoy EC, d'Angelo WA, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980;23:183-9.
8. Ganczarczyk L, Lee P, Armstrong S. Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 1988;31:116-9.
9. Spencer-Green G, Crowe W, Levinson J. Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. Arthritis Rheum 1982;25:954-8.
10. Silver RM, Maricq HR. Childhood dermatomyositis: serial microvascular studies. Pediatrics 1989;83:278-83.
11. Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED. Raynaud syndrome in childhood. J Pediatr 1989;114:73-8.
12. Lee P, Leung F, Alderdice C, Armstrong S. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983;10:930-8.
13. Leeford F, Edwards JCW. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 1986;45:741-9.
14. Maricq HR. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvascular Research 1986;32:271-6.
15. Bukhari M. Herrick AL, Moore T, Manning J, Jayson MIV. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996;35:1127-31.
16. Scheja A, Åkesson A, Niewierowicz I, Wallin L, Wildt M, Wollheim FA. Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 1996;55:52-6.
17. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16:328-34.
18. Andrade LEC, Gabriel A Jr., Assad RL, Ferrari AJL, Atra E. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1991;20:21-31.
19. Cony M, Klene-Boudard C, Fontan I, et al. Etude des aspects capillaroscopiques péri-unguéaux chez l'enfant normal. Arch Fr Pediatr 1992;49:171-4.
20. Pachman LM. An update on juvenile dermatomyositis. Curr Opin Rheumatol 1995;7:437-41.
21. Spencer-Green G, Crowe W, Bove K, Levinson J. Correlation of muscle angiopathy with nailfold capillary abnormalities in childhood dermatomyositis. 11th European Conference. In: Proceedings of the 11th European Conference on Microcirculation 1980; Garmisch-Partenkirchen, Germany. Biblio Anat 1981; 20:702-7.
22. Granier F, Vayssairat M, Priollet P, Housset E. Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 1986;29:189-95.
23. Raynaud M. On local asphyxia and symmetrical gangrene of the extremities. In: Barlow T (trans.). Selected Monographs. London: New Sydenham Society; 1888:121.
24. Kahalen B, Matucci-Cerinic M. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995;38:1-4.
25. Bunker CB, Terenghi G, Springall DR, Polak JM, Dowd PM. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 1990;336:1530-3.
26. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329-34.
27. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995;37 Suppl 1:S74-S86.
28. Dalakas MC, IIIa I, Damhrosia JM. A controlled trial of high dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
29. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994;94:1729-35.